Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07246213

CAYA Cancer Retrospective Cohort Study

Sponsor: Resonance, Inc.

View on ClinicalTrials.gov

Summary

Despite advances in cancer treatment, significant disparities in outcomes persist between high-income countries (HICs) and low-and middle-income countries (LMICs). Around 80% of children with cancer live in LMICs, where they face challenges such as delayed diagnosis, misdiagnosis, comorbidities, distance to treatment, financial barriers, and limited access to risk-adapted therapies. Acute lymphoblastic leukemia(ALL)/lymphoblastic lymphoma(LBL), for example, is one of the greatest success stories in pediatric oncology, however, such improvements are not evenly distributed worldwide, and the outcomes for leukemia patients are poorer in LMICs compared to HICs, primarily due to reduced access to quality healthcare. This study aims to assess cancer treatment outcomes in LMICs, focusing on acute lymphoblastic leukemia/lymphoblastic lymphoma. The findings will inform future studies to implement evidence-based interventions that improve care quality and reduce treatment failures through targeted strategies.

Official title: Improving Cancer Outcomes for Children, Adolescents, and Young Adults: A Multicenter Retrospective Cohort Study on Treatment Failure and Toxicity in Low- and Middle-Income Countries

Key Details

Gender

All

Age Range

0 Years - 21 Years

Study Type

OBSERVATIONAL

Enrollment

18000

Start Date

2025-06-04

Completion Date

2028-12-04

Last Updated

2025-12-19

Healthy Volunteers

No

Interventions

OTHER

Retrospective Medical Record Review

This study involves retrospective review of medical records of pediatric, adolescent, and young adult cancer patients (ages 0-21 years) treated at participating oncology centers in Guatemala, Honduras, El Salvador, Armenia, and Tanzania. No experimental drug, device, or behavioral intervention is being administered. Data abstraction will be performed to assess treatment failure, therapy-related toxicities, and clinical outcomes.

Locations (5)

Yeolyan Center for Cancer and Blood Disorders

Yerevan, Armenia

Fundación Ayúdame a Vivir

El Salvador, El Salvador, El Salvador

Unidad Nacional de Oncología Pediátrica (UNOP)

Guatemala City, Guatemala

Hospital Mario Catarino Rivas

San Pedro Sula, Cortés Department, Honduras

Hospital Escuela

Tegucigalpa, Distrito Central, Honduras